Tag Archives: BristolMyers

Bristol-Myers yanked its Celgene bid days before deadline—and got a better price

On Dec. 10, Bristol-Myers Squibb made what it said was its final offer to acquire Celgene. But it turns out that wasn’t the case. It ended up scoring a better deal instead. Just days before a Jan. 2 deadline Bristol-Myers itself had set for wrapping up an agreement, the New Jersey drugmaker pulled that proposal—$ 57… Read More »

The skeptics were right: Bristol-Myers has pulled a crucial Opdivo lung filing as it awaits more data

Investors panicked back in October when Bristol-Myers Squibb admitted that a request for additional data from a key lung cancer trial had pushed back an FDA decision. And perhaps rightly so. Thursday, the company said it had voluntarily pulled its application for an Opdivo-Yervoy pairing in a subset of patients with previously untreated non-small cell lung… Read More »